About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary

Navelbine

Navelbine Bibliography


Non-Small Cell Lung Cancer

Bakker M, Groen HJM, Dieben-Paauwen J, Smeets J, Riggi M. High-dose epirubicin (E) and vinorelbine (V) in previously untreated advanced non-small cell lung cancer (NSCLC): A feasibility study. Proc Am Soc Clin Oncol 1994;13:360, Abs No. 1213.

Balbiani L, Coppola F, Blajman C, Giacheila FO, Chacon R, Capo A, et al. Navelbine (NVB) vs NVB plus Cisplatin (P) in non-small lung cancer (NSCLC). Proc Am Soc Clin Oncol 1993;12:352, Abs No. 1185 (#5630561/2).

Baldini E, Tibaldi C, Chella A, Angeletti CA, Romanini A, Andrei A, et al. Combination chemotherapy with vinorelbine, ifosfamide and cisplatin: A phase II study in stage IIIB-IV non-small cell lung cancer. Semin Oncol 1994;21(3, Suppl 4):12-5 (#6677535/2).

Bensmaine MA, Monnet I, Cvitkovic E, Fandi A, Ruffle P, Hagipantelli R, et al. Cisplatin (P)/5-fluorouracil (5-FU) and escalating doses of vinorelbine (VNB) for advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:359, Abs No. 1207.

Bertelli P, Mantica C, Fanna G, Cobelli S, La Verde N, Gramegna G, et al. Treatment of non-small cell lung cancer with vinorelbine. Proc Am Soc Clin Oncol 1994;13:362, Abs No. 1218.

Berthaud P, Le Chevalier T, Ruffie P, Baldeyrou P, Arriagada R, Besson F, et al. Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer. Eur J Cancer 1992;28A(11):1863-5 (#3883793/2).

Brooks BJ, Gralla RJ, McGaw HJ, Otten MC, Lang AC, Rittenberg CN. Cisplatin + vinorelbine (Navelbine) combination chemotherapy for advanced non-small cell lung cancer: Testing the efficacy of a regimen designed to reduce toxicity and increase dose-intensity. Proc Am Soc Clin Oncol 1994;13:348, Abs No. 1162.

Carles P, Quoix E, Guerin JC, Tonnel AB, Bonnaud F, Nouvet G, et al. Presentation of Navelbine combinations in the treatment of non-small cell lung cancer. In: Solal-Celigny P, editor. Navelbine (vinorelbine): update and new trends. Paris: John Libbey Eurotex, 1991;137-40.

Carrato A, Rosell R, Artal A, Gomez RG, Aranda E, Massuti B, et al. Preliminary results of a phase II trial of biweekly vinorelbine as a single-agent in non-small cell lung cancer (NSCLC). Spanish Lung Cancer Group. Proc Am Soc Clin Oncol 1994;13:338, Abs No. 1125.

Comella P, Casaretti R, Daponte A, Cannada-Bartoli G, Parziale AP, Palmieri G, et al. Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: A pilot study. J Chemother 1994;6(1): 67-71 (#6674563/3).

Crawford J, O'Rourke MA, Hohneker J, Burman S. A phase I/II trial of dose escalation of Navelbine in combination with carboplatin in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:351, Abs No. 1176.

Crawford J O'Rourke MA. Vinorelbine (Navelbine)/carboplatin combination therapy: Dose intensification with granulocyte colony-stimulating factor. Semin Oncol 1994;21(5 Suppl 10):73-8.

Crivellari D, Veronesi A, Sacco C, Magri MD, Buonadonna A, Foladore S, et al. Phase II study of vinorelbine (V) in 50 patients (PTS) with non-small cell lunger cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:355, Abs No. 1192.

Depierre A, Lemarie E, Dabouis G, Garnier G, Jacoulet P, Dalphin JC. A phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol Cancer Clin Trials 1991;14(2):115-9 (#1977471/2).

Depierre A, Chastang C, Quoix E, Lebeau B, Blanchon F, Paillot N, et al. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial. Ann Oncol 1994;5(1):37-42 (#6038990/2).

Drinkard L, Samuels B, Hoffman P, Iwersen K, Golomb H, Bitran M, et al. A phase I-II trial of cisplatin (CDDP), 5 fluorouracil (5FU), leucovorin, (PFL), and Navelbine (NVB) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1993;12:356, Abs No. 1203 (#5854229/2).

Drinkard L, Hoffman P, Bitran J, Samuels B, Golomb H, Haraf D, et al. A phase I-II trial of Navelbine (N) and ifosfamide (I) with granulocyte colony stimulating factor (G-CSF) support in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:354, Abs No. 1186.

Drinkard L, Samuels B, Hoffman P, Golomb H, Bitran J, Ferguson M, et al. A phase I-II trial of cisplatin, 5-fluorouracil, leucovorin, and Navelbine in advanced non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):122, Abs No. 466.

Fernandez O, Bruno S, Mickiewicz E, Goldfarb A, Piris N, Katz A, et al. Randomized prospective comparison of Navelbine (NVB) and cisplatin (CDDP) versus Navelbine alone in patients with inoperable non-small cell lung cancer (NSLC). J Cancer Res Clin Oncol 1990;116(Suppl; pt1):111, Abs No. B1.137.39 (#4450593/2).

Gridelli C, De Placido S, Pepe R, Incoronato P, Airoma G, Rossi A, et al. Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. Eur J Cancer 1993;29A(12):1729-31 (#5477902/2).

Gridelli C, Rossi A, Palazzolo G, Pepe R, Airoma G, Incoronato P, et al. Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non-small cell lung cancer. Tumori 1994;80(2):128-30 (94/08625).

Jacoulet P, Dubiez A, Depierre A, Pugin JF, Pernet D. One-week vs 3-week intervals in the administration of cisplatin in combination with vinorelbine: A randomized study in non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1992;11:301, Abs No. 1013 (#4077623/2).

Jacoulet P, Depierre A, Garnier G, Dalphin JC. Study of combined Navelbine-cisplatin-VP16 in the treatment of non-small cell lung cancer. In: Solal-Celigny P, editor. Navelbine (vinorelbine): update and new trends. Paris: John Libbey Eurotex, 1991:171-7.

Kusunoki Y, Furuse K, Yamori S, Niitani H, Sakuma A, Fukuoka M, et al. Randomized phase II study of vinorelbine vs vindesine in previously untreated non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):113, Abs No. 429.

Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994;12(2):360-7 (#6037285/2).

Lonardi F, Pavanato G, Jirillo A, Ferrari V, Bonciarelli G, Balli M. Vinorelbine (VNB) as single-agent chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (PTS). Proc Am Soc Clin Oncol 1994;13:338, Abs No. 1123.

Malzyner A, Caponero R, Donato EM, Nadalin W, Vargas FS. Methotrexate, mitomycin C, vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994; 11(Suppl 1):123, Abs No. 469.

Marantz A, Lewi D, Litovska S. Phase II study of vinorelvine (VN) and ifosfamide (IFX) for non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:325, Abs No. 1071.

Masotti A, Zannini G, Poggi R, Morandini GC. Vinorelbine monochemotherapy in non-small cell lung cancer: Experience in patients with low performance status. Monaldi Arch Chest Dis 1994;49(3):197-200 (94/08897).

Monnet I, Azli N, Voisin S, Ruffie P, Vergnes L, Huet J, et al. Fluorouracil (FU)/folinic acid (FA) vinorelbine (VNB) cisplatin (P) in non-small cell lung cancer (NSCLC): A phase II study. Ann Oncol 1992;3(Suppl 5):31, Abs No. 122 (#4797560/2).

Morere JF, Brunet A, Duran A, Boaziz C, Israel L, Breau JL. Ifosfamide (IFX) and vinorelbine (NVB) in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1994;13:344, Abs No. 1149.

O'Rourke M, Crawford J, Schiller J, Laufman L, Yanovich S, Ozer H, et al. Survival advantage for patients with stage IV NSCLC treated with single agent Navelbine in a randomized controlled trial. Proc Am Soc Clin Oncol 1993;12:343, Abs No. 1148 (#5854232/2).

Perol M, Guerin JC, Kleisbauer JP, Poirier R, Carles P, Robinet G, et al. Multicenter randomized trial comparing cisplatin-mitomycin-vindesine vs cisplatin-mitomycin-Navelbine in advanced non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):114, Abs No. 434.

Piazza E, Filipazzi V, Rho B, Isa L, Scapaticci R, Pavia G, et al. Cisplatin-vinorelbine association chemotherapy in the treatment of locally advanced NSCLC. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):128, Abs No. 490. Rinaldi M, Della Giulia M, Venturo I, Del Medico P, Serrone L, Capomolla E, et al. Vinorelbine (VNB) as single agent in the treatment of advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994;13:360, Abs No. 1212.

Santomaggio C, Righi R, Tucci E, Pepi F, Algeri R, Andrei A. Carboplatin and vinorelbine in metastatic non-small cell lung cancer. Preliminary results. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):125, Abs No. 478.

Santoro A, Maiorino L, Santoro M. Second-line with vinorelbine in the weekly monochemotherapy for the treatment of advanced non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):130, Abs No. 497.

Tredaniel J, Dieras V, Ferme C, Marty M, Hirsch A. Alternate to cisplatin: 5FU-Navelbine combination. In: Solal-Celigny P, editor. Navelbine (vinorelbine): update and new trends. Paris: John Libbey Eurotex, 1991;163-9.

Vergnenegre A, Pham E, Perol M, Bonnaud F. Cost effectiveness analysis of two chemotherapy regimens in a randomized multicenter trial for stage III and stage IV non-small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1A):113, Abs No. 321.

Viallet J, Ayoub J, Rousseau P, Souhami L, Hohneker J, Shepherd F. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer. Semin Oncol 1994;21(5 Suppl 10):64-72.

Vokes EE, Drinkard LC, Samuels BL, Hoffman PC, Watson S, Bitran JD, Haraf DJ, et al. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: Rationale and study design. Semin Oncol 1994;21(5 Suppl 10):79-84.

Yokoyama A, Furuse K, Niitani H. Multi-institutional phase II study of Navelbine (vinorelbine) in non-small cell lung cancer. Proc Am Soc Clin Oncol 1992;11:287, Abs No. 957 (#4077630/2).

Yamamoto M, Furuse K, Hasegawa K, Kurita Y, Ariyoshi Y, Fukuoka M, et al. A phase I study of Navelbine (vinorelbine) combined with cisplatin in non-small cell lung cancer patients. Ann Oncol 1992;3(Suppl 1):124, Abs No. 263 (#3134577/2).


Top | Lung Library Index | Navelbine Index | Navelbine Bibliography | Next ]

About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary